MARKER THERAPEUTICS, INC. Proceeds from Construction Loans Payable
MARKER THERAPEUTICS, INC. (MRKR) reported Proceeds from Construction Loans Payable of $7.43 million for the 9-month period ending 2015-09-30, per its 10-Q/A filed 2016-04-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConstructionLoansPayable · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. proceeds from construction loans payable for the quarter ending 2014-09-30 was $0.00.
| Period end | Proceeds from Construction Loans Payable 3 month | Proceeds from Construction Loans Payable 6 month | Proceeds from Construction Loans Payable 9 month |
|---|---|---|---|
| 2015-09-30 | $7.43M 10-Q/A · filed 2016-04-14 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2015-11-16 | $500.00 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $500.00 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |